Application analysis of quality sensitive indicators combined with progressive nursing in disinfection supply room
质量敏感指标联合阶段递进式护理在消毒供应室中的应用分析

摘要

目的 探讨质量敏感指标联合阶段递进式护理在消毒供应室中的应用效果。方法 研究于2025年1月-2026年1月期间选择本院护理人员30例，共计处理器械2000件，每组各1000件，采用随机数字表法将护理人员分为观察组和对照组。对照组采取常规流程管理模式，观察组的15名护理人员采取质量敏感指标联合阶段递进式护理模式，以此比较两组器械灭菌达标率、器械功能完好程度、临床科室满意度和不良事件发生率。结果 观察组灭菌达标率更高（P＜0.05）；观察组的器械功能完好程度更佳（P＜0.05）；观察组的临床科室满意度显著优于对照组（P＜0.05）；观察组的不良事件发生率低于对照组（P＜0.05）。结论 质量敏感指标联合阶段递进式护理在消毒供应室中能够起到显著作用，有效加强灭菌效果，提高器械功能完好程度，增强临床科室满意度，降低不良事件发生率，值得临床推广应用。

Abstract

Objective To explore the application effect of quality sensitive indicators combined with progressive nursing in disinfection supply rooms.
Methods From January 2025 to January 2026, a total of 30 nursing staff members were selected from our hospital, with a total of 2000 surgical instruments, 1000 in each group. The nursing staff were randomly divided into an observation group and a control group using a random number table method. The control group adopted a conventional process management mode, while the 15 nursing staff in the observation group adopted a quality sensitive index combined stage progressive nursing mode, in order to compare the sterilization compliance rate, functional integrity of the instruments, clinical department satisfaction, and incidence of adverse events between the two groups.
Results The observation group had a higher sterilization compliance rate (P<0.05); The observation group showed better functional integrity of the instruments (P<0.05); The clinical department satisfaction of the observation group was significantly better than that of the control group (P<0.05); The incidence of adverse events in the observation group was lower than that in the control group (P<0.05).
Conclusion   The combination of quality sensitive indicators and phased progressive nursing can play a significant role in disinfection supply rooms, effectively enhancing sterilization effectiveness, improving instrument functionality, enhancing clinical department satisfaction, and reducing the incidence of adverse events. It is worthy of clinical promotion and application.